REGN5093-M114
R5093-M114-ONC-1864
Phase 1 small_molecule terminated
Quick answer
REGN5093-M114 for Advanced NSCLC is a Phase 1 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Advanced NSCLC
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated